DRUG · Unmapped registry intervention
VPI-2690B low dose
Find medicine records ·
Find other trials using this name
Clinical trial
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
NCT02251067
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
VPI-2690B medium dose
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo to match VPI-2690B
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
VPI-2690B high dose
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPhase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Vascular Pharmaceuticals, Inc.lead sponsor
Mapped research locations
BostonMassachusetts, United States1MiamiFlorida, United States1San AntonioTexas, United States1NashvilleTennessee, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1Las VegasNevada, United States1Winston-SalemNorth Carolina, United States1SacramentoCalifornia, United States1Little RockArkansas, United States1Kansas CityMissouri, United States1AlbanyNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02251067 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.